Khartis Therapeutics Secures $50M to Advance Thyroid Eye Disease Drug

San Diego, Calif.-based Khartis Therapeutics has raised $50 million in Series B financing led by Forge Life Science Partners, with... Read More

The post Khartis Therapeutics Secures $50M to Advance Thyroid Eye Disease Drug appeared first on citybiz.